China
YuanMing, Matrix lead $50m round for China's Adlai Nortye
YuanMing Capital and Matrix Partners China have led a Series B round of more than $50 million – denominated in US dollars and renminbi – for Adlai Nortye, a Chinese biopharmaceutical company.
C-Bridge leads $20m round for China's Nuance
C-Bridge Capital, a Chinese healthcare-focused private equity firm, has led a $20 million Series B funding round for domestic pharmaceuticals developer Nuance Biotech.
Uxin trades up on debut after $225m US IPO
Chinese used car trading platform Uxin Group gained 10% on its first day of trading on NASDAQ following a $225 million IPO that was scaled back in terms of size and pricing.
VIDEO: Morrison & Foerster's Serena Tan
Serena Tan, a partner at Morrison & Foerster, discusses trends in private equity fundraising in China
PE-backed Zhaogang files Hong Kong IPO
Zhaogang, a Chinese B2B steel-trading platform operator that has raised more than RMB2 billion ($303 million) across five PE-backed funding rounds, has filed for a Hong Kong IPO.
Deal focus: VCs see profits as VIPKid goes young
China's online English language education start-up VIPKid has raised $500 million in Series D-plus funding to grow its youth-focused teaching business
China Renaissance targets $800m in Hong Kong offering
China Renaissance Holdings has filed for an IPO in Hong Kong that will support the expansion of its investment banking, investment management, and wealth management businesses. AVCJ understands the firm is planning to raise $800 million at a valuation...
China launches $4.6b technology-focused guidance fund
The Beijing government has launched a RMB30 billion ($4.6 billion) innovation-focused fund-of-funds that will not only make investments locally but also commit capital overseas with a view to bringing technologies to China.
Meituan-Dianping set for bumper Hong Kong listing
Meituan-Dianping, China’s leading online-to-offline (O2O) platform that offers lifestyle services ranging from hotel booking to food delivery to bike-sharing, has filed for an IPO in Hong Kong.
CITIC Securities fund makes pre-IPO investment in ESR
China’s CITIC Securities has made a pre-IPO investment of undisclosed size in pan-Asian logistic company and fund manager E-Shang Redwood (ESR).
Matrix raises $750m for fifth China VC fund
Matrix Partners China has raised $750 million for its fifth venture capital fund to invest in the technology, cleantech, education, energy, healthcare and financial services sectors in China.
China's VIPKid raises $500m round
China-based English language learning platform operator VIPKid has received a $500 million funding round led by Sequoia Capital, Tencent Investment, Yunfeng Capital, and Coatue Management.
Hong Kong biotech IPOs: Capital injection
The move to allow zero-revenue biotech companies to list in Hong Kong has spurred investor interest in healthcare. But valuations are high and success in this capital-intensive space is by no means guaranteed
China cross-border GP AGIC opens London office
AGIC Capital, a private equity firm focused on China-Europe cross-border investments, has opened an office in London to access new investment opportunities and grow its investor base.
Deal focus: Byton plans China luxury breakthrough
Legend Capital-backed Byton plans to pursue global expansion in the luxury electric car market with the help of a $500 million Series B round
PE-backed VCredit raises $152m in HK IPO
VCredit, a Chinese online consumer finance platform with private equity backers including TPG Growth, has raised HK$1.2 billion ($152 million) in its Hong Kong IPO.
Qiming leads $37m round for China's Alpha Biopharma
China’s Qiming Venture Partners has led a $37 million Series A investment in domestic biopharmaceutical start-up Alpha Biopharma.
Centurium reaches $1b first close on China fund
Centurium Capital, the private equity firm established by ex-Warburg Pincus China head David Li, has reached a first close on its debut fund of nearly $1 billion.
CITIC Capital makes $3.6b bid for China Biologic Products
CITIC Capital has submitted a take-private bid for China Biologic Products that values the US-listed biopharmaceutical developer at approximately $3.65 billion.
Shunwei, DCM lead $65m round for China's Yaoshibang
Chinese B2B pharmaceutical trading and education platform Yaoshibang has received RMB420 million ($65 million) in Series C funding across two tranches.
China's Ono gets $16m Series A round
A group of VCs including China Growth Capital have agreed to invest $16 million in Ono, a China-based company that claims to be the creator of the first decentralized social network.
Australia-listed Sirtex accepts CDH's $1.4b buyout offer
Australian medical device manufacturer Sirtex Medical has accepted a A$1.9 billion ($1.4 billion) buyout offer from China’s CDH Investments, pulling the plug on an earlier agreement with US-listed Varian Medical Systems.
China early-stage investment round-up
Venture capital deals involving IDG Capital, Orchid Asia, Fosun Group, Matrix Partners, ZhenFund, Sky9 Capital, CDH Investments, Meridian Capital, Eastern Bell Venture Capital, SIG, and Qianhai FoF
China Growth Capital leads round for Cheduoduo
China Growth Capital has led a $17.7 million Series A round of funding for Cheduoduo, a newly launched Chinese used car trading platform, with participation from Source Code Capital.